GLAXOSMITHKLINE PHARMACEUTICALS
|
The Current P/S Ratio of GLAXOSMITHKLINE PHARMACEUTICALS is 14.08.
Share Price | ₹3,117.3 | Jul 21,2025 |
Market Cap | ₹52,807.1 Cr | |
Sales-TTM | ₹3,749.2 Cr | TTM-Consolidated Results |
Price/Sales | 14.08x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of GLAXOSMITHKLINE PHARMACEUTICALS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹52,807.1 Cr] as on Jul 21,2025
(/) Sales [ ₹3,749.2 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 14.08x ]
Thus, for GLAXOSMITHKLINE PHARMACEUTICALS , the investors are currently willing to pay '14.08 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of GLAXOSMITHKLINE PHARMACEUTICALS !
The chart below summarizes the trend in P/S Ratio of GLAXOSMITHKLINE PHARMACEUTICALS over the last five years.
Historical PS (Price/Sales) ratio chart of GLAXOSMITHKLINE PHARMACEUTICALS
PS Ratio Performance Analysis for GLAXOSMITHKLINE PHARMACEUTICALS
- GLAXOSMITHKLINE PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 9.27x.
- GLAXOSMITHKLINE PHARMACEUTICALS 's operated at median p/e ratio of 8.59x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, GLAXOSMITHKLINE PHARMACEUTICALS 's p/e ratio peaked in Mar2025 at 13x.
- GLAXOSMITHKLINE PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2023 of 6.9x.
How does GLAXOSMITHKLINE PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
GLAXOSMITHKLINE PHARMACEUTICALS | 3,749.2 | 14.08 | 52,807.1 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 52,578.4 | 7.72 | 405,872.0 |
DIVIS LABORATORIES LTD | 9,360.0 | 18.98 | 177,609.0 |
CIPLA LTD | 27,547.6 | 4.33 | 119,184.0 |
TORRENT PHARMACEUTICALS LTD | 11,516.0 | 10.36 | 119,277.0 |
DR REDDYS LABORATORIES LTD | 32,643.9 | 3.22 | 105,116.0 |
MANKIND PHARMA LTD | 12,279.3 | 8.90 | 109,235.0 |
ZYDUS LIFESCIENCES LTD | 23,241.5 | 4.20 | 97,579.5 |
LUPIN LTD | 22,707.9 | 3.87 | 87,768.6 |
AUROBINDO PHARMA LTD | 31,723.7 | 2.08 | 66,121.4 |
ABBOTT INDIA LTD | 6,409.2 | 11.29 | 72,367.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs GLAXOSMITHKLINE PHARMACEUTICALS 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.08x |
Max industry PS | 18.98x |
Median industry PS | 7.72x |
Average industry PS | 8.09x |
You may also like the below Video Courses